Vor Bio says its experimental drug slowed loss of kidney function in late-stage study
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning
Vor Biopharma rises after positive autoimmune drug data
Vor Biopharma Inc. reports results for the quarter ended June 30 - Earnings Summary
Vor Biopharma posts wider-than-expected Q2 loss on increased G&A costs
Vor Biopharma Q1 net loss widens
Brief: Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Vor Bio Doses First Patient In Global Phase 3 Upstream Sjd Registrational Trial Of Telitacicept In Primary Sjögren’S Disease
Vor Biopharma Q4 profit tops estimates on warrant fair value gain
U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan
U.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
U.S. STOCKS ON THE MOVE-Alphabet, Phathom, Argan
Vor Bio climbs after announcing $75 mln private placement
Brief: Vor Bio Announces $75 Million Private Placement With Tcgx
Brief: Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Robinhood Markets, Cannabis stocks, Hyatt Hotels